These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11121455)

  • 1. Stem cell transplant numbers decline; research continues.
    Twombly R
    J Natl Cancer Inst; 2000 Dec; 92(24):1972-3. PubMed ID: 11121455
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Stem cell transplant numbers decline; research continues.
    Gratwohl A; Baldomero H
    J Natl Cancer Inst; 2001 Jun; 93(12):949. PubMed ID: 11416117
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cellular therapies in 2002].
    Bregni M
    Tumori; 2002; 88(6):A20-4. PubMed ID: 12597161
    [No Abstract]   [Full Text] [Related]  

  • 4. [From bone marrow transplantation to blood stem cell transplantation. Experiences from the first 100 autologous stem cell transplantation in Turku].
    Remes K; Rajamäki A; Grenman S; Itälä M; Kauppila M; Nikoskelainen J; Pelliniemi TT; Ristamäki R; Salmi TT; Salmi T; Salminen E; Vanharanta R; Toivanen A
    Duodecim; 1997; 113(3):219-28. PubMed ID: 11370030
    [No Abstract]   [Full Text] [Related]  

  • 5. [Stem cell reserve after autologous blood stem cell transplantation].
    Mayer F; Kanz L
    Internist (Berl); 1999 Mar; 40(3):323-5. PubMed ID: 10205761
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of cancer with high-dose chemotherapy and autologous stem cell transplantation].
    Geisler CH; Daugaard KG; Dickmeiss E; Ifversen M; Knudsen LM
    Ugeskr Laeger; 2003 Dec; 165(50):4846-9. PubMed ID: 14716902
    [No Abstract]   [Full Text] [Related]  

  • 7. Autologous stem cell transplantation for multiple myeloma: Long-term results.
    Kumar L; Boya RR; Pai R; Harish P; Mookerjee A; Sainath B; Patekar MB; Sahoo RK; Malik PS; Sharma OD; Gupta R
    Natl Med J India; 2016; 29(4):192-199. PubMed ID: 28050994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haematopoietic stem cell transplant activity in Switzerland 1997/1998: a report by the STABMT. Swisstransplant Working Group Blood and Marrow Transplantation.
    Schweiz Med Wochenschr; 2000 Jul; 130(27-28):1027-33. PubMed ID: 10953852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction: dose-intensive therapy for adult malignancies.
    Weiss RB
    Semin Oncol; 1999 Feb; 26(1):1-5. PubMed ID: 10073557
    [No Abstract]   [Full Text] [Related]  

  • 10. [High-dose chemotherapy with autologous stem cell transplantation--US-Japan Cooperative Cancer Research Program Seminar].
    Ogawa M
    Gan To Kagaku Ryoho; 1992 Jul; 19(7):1105-8. PubMed ID: 1352671
    [No Abstract]   [Full Text] [Related]  

  • 11. Overview of transplant activity in Europe.
    Gratwohl A;
    Hematol J; 2004; 5 Suppl 3():S29-33. PubMed ID: 15190274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic stem cell transplantation activity in Europe 1999.
    Gratwohl A; Passweg J; Baldomero H; Urbano-Ispizua A;
    Bone Marrow Transplant; 2001 May; 27(9):899-916. PubMed ID: 11436100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood and marrow transplantation activity in Europe 1996. European Group for Blood and Marrow Transplantation (EBMT).
    Gratwohl A; Passweg J; Baldomero H; Hermans J
    Bone Marrow Transplant; 1998 Aug; 22(3):227-40. PubMed ID: 9720735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study of addition of amifostine to melphalan, carboplatin, etoposide, and cyclophosphamide with autologous hematopoietic stem cell transplantation in pediatric solid tumors-A pediatric blood and marrow transplant consortium study.
    Ozkaynak MF; Sahdev I; Gross TG; Levine JE; Cheerva AC; Richards MK; Rozans MK; Shaw PJ; Kadota RP
    J Pediatr Hematol Oncol; 2008 Mar; 30(3):204-9. PubMed ID: 18376282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of peripheral blood progenitor cells as an autologous hematopoietic support in high-dose chemotherapy. I. The rationale and results].
    Silva MR; Passos-Coelho JL; da Costa FL; Machado MA; Miranda N; Miranda MH; Parreira A
    Acta Med Port; 1999; 12(7-11):265-73. PubMed ID: 10707464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dose intensity in anticancer chemotherapy. Paris, 19 December 1994].
    Droz JP; Maraninchi D
    Bull Cancer; 1995; 82 Suppl 1():1s-2s. PubMed ID: 7626848
    [No Abstract]   [Full Text] [Related]  

  • 17. [Gemtuzumab ozogamicin as monotherapy and combination therapy for acute myelogenous leukemia].
    Usui N
    Rinsho Ketsueki; 2007 Jun; 48(6):458-67. PubMed ID: 17633093
    [No Abstract]   [Full Text] [Related]  

  • 18. Administration of G-CSF can be delayed after transplantation of autologous G-CSF-primed blood stem cells: a randomized study.
    Faucher C; Le Corroller AG; Chabannon C; Novakovitch G; Manonni P; Moatti JP; Nouyrigat P; Maraninchi D; Blaise D
    Bone Marrow Transplant; 1996 Apr; 17(4):533-6. PubMed ID: 8722350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low prevalence of premature ovarian failure in women given reduced-intensity conditioning regimens for hematopoietic stem-cell transplantation.
    Cheng YC; Saliba RM; Rondón G; Giralt SA; Lu KH; Bodurka DC; Gershenson DM; Champlin RE; Ueno NT
    Haematologica; 2005 Dec; 90(12):1725-6. PubMed ID: 16330461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Check-Point Inhibitors before and after Allogeneic Hematopoietic Stem Cell Transplant: The Double-Edge Sword.
    Oran B; Daver N
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):e1-e2. PubMed ID: 30500441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.